| Date Filed | Type | Description |
| 06/12/2023 |
4
| Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 02/27/2023 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Enliven Therapeutics, Inc.|
Txns:
| Granted 149,820 shares
@ $0
Granted 37,407 shares
@ $0
Granted 31,172 shares
@ $0
Granted 20,657 options to buy
@ $2.48, valued at
$51.2k
|
|
| 02/27/2023 |
3
| Heyman Richard A. (Director) has filed a Form 3 on Enliven Therapeutics, Inc. |
| 09/06/2022 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $0.42, valued at
$6.9k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 53,700 options to buy
@ $3.75, valued at
$201.4k
|
|
| 06/06/2022 |
4
| Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 19,500 options to buy
@ $13.56, valued at
$264.4k
|
|
| 11/19/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 19,000 options to buy
@ $9.86, valued at
$187.3k
|
|
| 09/16/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 706 shares
@ $25.0511, valued at
$17.7k
Sold 682 shares
@ $25.0347, valued at
$17.1k
|
|
| 09/14/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 479 shares
@ $25.1005, valued at
$12k
Sold 601 shares
@ $25.0133, valued at
$15k
|
|
| 09/09/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 1,086 shares
@ $25.1125, valued at
$27.3k
|
|
| 07/23/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 5,781 options to buy
@ $28.33, valued at
$163.8k
|
|
| 06/17/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 16,625 options to buy
@ $19.03, valued at
$316.4k
|
|
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Metacrine, Inc.|
Txns:
| Granted 16,500 options to buy
@ $4.07, valued at
$67.2k
|
|
| 05/24/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 700 shares
@ $25.0829, valued at
$17.6k
Sold 600 shares
@ $25.25, valued at
$15.2k
Sold 100 shares
@ $25, valued at
$2.5k
|
|
| 05/18/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 3,215 shares
@ $25.3133, valued at
$81.4k
Sold 498 shares
@ $25.0679, valued at
$12.5k
Sold 2,161 shares
@ $25.3195, valued at
$54.7k
|
|
| 05/13/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 100 shares
@ $25.11, valued at
$2.5k
|
|
| 04/30/2021 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Sold 100 shares
@ $25.08, valued at
$2.5k
Sold 100 shares
@ $25.26, valued at
$2.5k
|
|
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Heyman Richard A. (Director) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.|
Txns:
| Granted 6,158 shares
@ $0
Granted 5,271 options to buy
@ $8.16, valued at
$43k
|
|
| 12/28/2020 |
3
| Heyman Richard A. (Director) has filed a Form 3 on YUMANITY THERAPEUTICS, INC. |
| 11/12/2020 |
4
| Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 45,332 options to buy
@ $4.22, valued at
$191.3k
|
|
| 09/24/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/16/2020 |
3
| Heyman Richard A. (Director) has filed a Form 3 on Metacrine, Inc. |
| 09/03/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/22/2020 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 12,500 options to buy
@ $6.66, valued at
$83.3k
|
|
| 04/28/2020 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Converted 62,500 shares
@ $0
Converted 62,500 preferred shares
@ $0 |
|
| 04/27/2020 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 16,625 options to buy
@ $16, valued at
$266k
|
|
| 04/23/2020 |
3
| Heyman Richard A. (Director) has filed a Form 3 on Oric Pharmaceuticals, Inc. |
| 06/20/2019 |
4
| Heyman Richard A. (Director) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 8,570 options to buy
@ $10.86, valued at
$93.1k
|
|